A detailed history of Signature Wealth Management Partners, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Signature Wealth Management Partners, LLC holds 10,780 shares of TGTX stock, worth $262,600. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,780
Previous 10,780 -0.0%
Holding current value
$262,600
Previous $191,000 31.94%
% of portfolio
0.18%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

BUY
$6.68 - $18.81 $72,010 - $202,771
10,780 New
10,780 $184,000
Q2 2023

Jul 24, 2023

BUY
$15.48 - $35.0 $130,186 - $294,350
8,410 New
8,410 $208,000
Q2 2021

Jul 29, 2021

SELL
$32.5 - $48.96 $140,725 - $211,996
-4,330 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$41.61 - $54.3 $180,171 - $235,119
4,330 New
4,330 $209,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.54B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Signature Wealth Management Partners, LLC Portfolio

Follow Signature Wealth Management Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Wealth Management Partners, LLC with notifications on news.